$SPDR S&P Biotech ETF (XBI.US)$$iShares Biotechnology ETF (IBB.US)$ Observations from $VINC (-60% AH): 1- When companies tout "strong safety profile", often means efficacy is a big fat zero 2- Phrases like "dose dependent clinical activity" set the bar low 3- "Promising" doesn't necessarily refer to SP Stay skeptical, my friends.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more